KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Inventory Average (2016 - 2025)

Historic Inventory Average for Jazz Pharmaceuticals (JAZZ) over the last 17 years, with Q3 2025 value amounting to $494.0 million.

  • Jazz Pharmaceuticals' Inventory Average fell 866.63% to $494.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $494.0 million, marking a year-over-year decrease of 866.63%. This contributed to the annual value of $538.7 million for FY2024, which is 1781.83% down from last year.
  • Per Jazz Pharmaceuticals' latest filing, its Inventory Average stood at $494.0 million for Q3 2025, which was down 866.63% from $498.9 million recorded in Q2 2025.
  • Over the past 5 years, Jazz Pharmaceuticals' Inventory Average peaked at $1.2 billion during Q3 2021, and registered a low of $105.4 million during Q1 2021.
  • Moreover, its 5-year median value for Inventory Average was $634.5 million (2023), whereas its average is $675.5 million.
  • In the last 5 years, Jazz Pharmaceuticals' Inventory Average surged by 119886.7% in 2021 and then crashed by 3476.19% in 2022.
  • Jazz Pharmaceuticals' Inventory Average (Quarter) stood at $1.1 billion in 2021, then plummeted by 34.76% to $721.1 million in 2022, then decreased by 16.18% to $604.4 million in 2023, then decreased by 15.64% to $509.9 million in 2024, then dropped by 3.1% to $494.0 million in 2025.
  • Its Inventory Average stands at $494.0 million for Q3 2025, versus $498.9 million for Q2 2025 and $486.6 million for Q1 2025.